ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Study of Tazemetostat in Combination With Lenalidomide & Rituximab in R/R FL

19 views
June 8, 2022
Comments 0
Login to view comments. Click here to Login